approvals Articles - Easy Trading Signals

Biotechnology Catalysts: Positive Phase 2 Results Show Higher Gains Than FDA Approvals

Investment thesis: Biotechnology investors work on the assumption that news surrounding assets in clinical development impact company valuation significantly. Our analysis suggests that focusing on earlier events, such as Phase 2 and 3 data release, represents a stronger short-term, catalyst-based investment strategy in the biotechnology sector, relative to PDUFA events.Read More →

Boeing survey found 1 in 3 employees felt ‘undue pressure’ over safety approvals

By: Staff Writer

U.S. lawmakers probing the 737 Max jet crisis are ratcheting up scrutiny of Boeing Co. leaders as new details point to management pressure on engineers and pilots in its commercial-aircraft unit. Investigators for the House Transportation and Infrastructure Committee looking into the design and certification of the 737 Max haveRead More →